Inicio › Cáncer metastásico › Washington › Seattle
Ensayos clínicos de Cáncer metastásico en Seattle, WA
39 estudios para Cáncer metastásico buscan participantes en centros de Seattle y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Swedish Medical Center-First Hill, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
ReclutandoFase 3
- University of Washington Fred Hutchinson Cancer Center, Seattle
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
ReclutandoFase 1
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
ReclutandoFase 2/3
- Fred Hutchinson Cancer Center, Seattle
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center, Seattle
- y 1 más
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutandoFase 1
- Swedish Cancer Institute, Seattle
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
ReclutandoFase 2/3
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- Fred Hutchinson Cancer Center, Seattle
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
ReclutandoFase 1/2
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- Swedish Medical Center, Seattle
SLV-154 Treatment of Advanced Cancers
ReclutandoFase 1
- University of Washington / Fred Hutchinson Cancer Center, Seattle
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
ReclutandoFase 3
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
- University Of Washington Medical Center, Seattle
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center ( Site 0013), Seattle
A Study of KK2269 in Adult Participants With Solid Tumors
ReclutandoFase 1
- University of Washington, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ReclutandoFase 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ReclutandoFase 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Fred Hutchinson Cancer Research Center, Seattle
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
ReclutandoSe aceptan voluntarios sanos
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center - Montlake, Seattle
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
ReclutandoFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
ReclutandoFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
ReclutandoFase 2
- VA Puget Sound Health Care System, Seattle
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ReclutandoFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ReclutandoFase 3
- Fred Hutchinson Cancer Center, Seattle
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Virginia Mason Medical Center, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Mason Medical Center, Seattle
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
ReclutandoFase 2/3
- Fred Hutchinson Cancer Research Center, Seattle
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
ReclutandoFase 2/3
- Fred Hutchinson Cancer Center, Seattle
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Seattle
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
ReclutandoFase 1
- Fred Hutch Cancer Center, Seattle
A Study of NX-1607 in Adults With Advanced Malignancies
ReclutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
Ensayos de Cáncer metastásico en otras ciudades
- Houston, TX104 estudios
- New York City, NY93 estudios
- Nashville, TN70 estudios
- Boston, MA63 estudios
- Los Angeles, CA57 estudios
- St. Louis, MO54 estudios
- Arlington, VA53 estudios
- Philadelphia, PA46 estudios
- Chicago, IL45 estudios
- San Antonio, TX44 estudios
- Washington, DC43 estudios
- Dallas, TX42 estudios
Otros estudios en Seattle
- Cáncer de pulmón de células no pequeñas53 estudios
- Cáncer (todos los tipos)49 estudios
- Cáncer de próstata42 estudios
- Leucemia mielógena aguda40 estudios
- Cáncer de seno39 estudios
- Cáncer del colon y del recto34 estudios
- Cáncer de pulmón33 estudios
- Cáncer de ovario30 estudios
- Mieloma múltiple22 estudios
- Síndromes mielodisplásicos21 estudios
- Leucemia linfoblástica aguda21 estudios
- Cáncer de vejiga21 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.